Kim Ha-seong’s teammate Darvish Yu (San Diego Padres) will have to wait until next year to reach 200 career wins in the United States and Japan.
“Darvish was placed on the 15-day disabled list (IL) with right elbow inflammation,” MLB.com, the official website of Major League Baseball (MLB), reported on Monday (April 29). The IL stint was retroactive to Sept. 27.
Darvish, who was 8-10 with a 4.56 ERA this season, was one win away from his 200th career U.S.-Japan victory. With 93 wins in the Nippon Professional Baseball League (NPB) from 2005 to 2011 and 103 wins in the MLB since 2012, he was just four wins away from 200 with 196 career wins, but the injury puts his chances of reaching the milestone this year in doubt.
While the season isn’t over yet, it’s unclear if Darvish will pitch the rest of the season. Not least because the team is in bad shape. San Diego is currently in fourth place in the National League West with a record of 62 wins, 71 losses, and a .466 winning percentage. They’re also in the seventh wild card spot, 7.5 games behind the third-place San Francisco Giants. Realistically, the team’s chances of making it to fall ball are slim, so some have questioned whether Darvish is being overused.
“With San Diego out of wild-card contention, is it worth it to push Darvish’s return,” said MLB.com Padres expert A.J. Casabell. “The worst-case scenario is that it’s a short-sighted decision and he aggravates the injury, causing lingering damage for next season. Even if the player wants to return in mid-September, his long-term health is more important.” Darvish signed a six-year, $108 million contract with San Diego in February. He’s paid through 2028, and the team’s point is that it would be a disservice to him if he aggravated his injury by overdoing it.카지노사이트
According to the media, the club has not yet received the exact results of Darvish’s medical examination. As soon as they do, the team will discuss a timetable for his return. It will also determine whether Darvish will be able to reach 200 career wins in the U.S. and Japan this year.